Draft Version 1.110

tblLAB_HCV

  • Added table

tblVIS_SUBS

  • Added table

tblART

  • Added new options to ART_ID

    • J05AF13

    • J05AG06

    • J05AR20

    • J05AR21

    • J05AR22

    • J05AR24

    • J05AR25

  • Added new options to ART_RS

    • 92.91 : Change to generic drug

    • 92.92 : Change to branded drug

tblBAS

  • Redesigned codes for ETHNIC

    • 100 = White/Caucasian

    • 110 = White, European

    • 200 = Black

    • 204 = Other Black

    • 210 = Sub-Saharan African

    • 220 = Caribbean

    • 230 = African-American

    • 250 = Black, African

    • 300 = Hispanic/Latinx

    • 400 = Asian

    • 410 = East Asian (e.g. Chinese, Japanese)

    • 411 = Chinese

    • 412 = Japanese

    • 420 = Southeast Asia (e.g. Thai, Vietnamese, Philippino)

    • 421 = Indian Subcontinent (Indian, Pakistani, Bangladeshi)

    • 430 = South Asian (e.g. Indian, Pakistani)

    • 800 = Other ethnic groups

    • 810 = Maghrebian

    • 820 = Middle East/Arab

    • 830 = Turkish

    • 840 = Roma people/Gypsy (whichever is term is acceptable)

    • 850 = Indigenous people from Americas or Alaska Native

    • 860 = Indigenous people from other continents/locations

    • 900 = Mixed race/ethnicity

    • 910 = Do not want to disclose

    • 980 = Prohibited

    • 999 = Unknown

  • Renamed GENDER to SEX

tblVIS

  • Renamed GENDER_ID to GENDER_IDENT

  • Added codes to GENDER_IDENT

    • 6 = Non-binary

tblCEP

  • Added new codes to CEP_ID

    • CTAB

    • ARFI

    • Added codes to CEP_SPEC, for CEP_ID = FRA

    • SKUL

    • FABO

    • COLB

    • SHOU

    • UPAR

    • LOAR

    • FING

    • RIB

    • TOSP

    • CESP

    • LUSP

    • FEM

    • HIP

    • LOLG

    • TOE

    • OTH

  • Added codes to CEP_V, for CEP_ID = FRA

    • 1 = Traumatic

    • 2 = Osteoporotic/Fragility

    • 3 = Pathologic

tblLAB_RES

  • Added new optional field TESTTYPE_M

tblLAB_VIRO

  • Added new codes to VS_T

    • 10 = Rapid diagnostic test -3rd generation [HIV]

    • 11 = Rapid diagnostic test -4th generation [HIV]

    • 12 = Self-test-oral [HIV]

    • 13 = Self-test-blood-based [HIV]

    • 14 = Immunoassay (EIA, CLIA, ECL) - 3rd generation [HIV]

    • 15 = Immunoassay (EIA,CLIA, ECL) plus p24 - 4th generation [HIV]

    • 16 = WB: Western blot/immunoblot [HIV]

    • 17 = NAT (Nucleic Acid Test) [HIV]

Previous versions

Version 1.100

tblART_MUM

  • Added table

tblART

  • Added new optional field ART_FORM

  • Added new optional field ART_COMB

  • Added new optional field ART_START_RS

  • Added coding table with reasons for medication start ART_START_RS

tblBAS

  • Removed field CENTER as it is available in

tblVIS

  • Added new optional field PROPH_Y Extended coding table of field MODE

  • Added Code 9 (sexual contact homo/hetero not specified)

  • Added Code 10 (sexual abuse)

tblCENTER

  • Added new optional field SURVEY_INTERNET

  • Added new optional field SURVEY_PAPER

  • Added new optional field LAST_REVIEWED_D tblDELIVERY_CHILD

  • Added new optional field CHILD_ENROL tblDELIVERY_MUM

  • Added new optional field ROM_DUR

  • Added new optional field ROM_DUR_A

  • Added new optional field DELIVERY_LOCATION

  • Added new optional field PLANNED_HOME

  • Added new optional field DELIV_ASSIST

tblDIS

  • Added new optional field DIS_OUTCOME

  • Added new optional field DIS_SITE

  • Added various codes to coding table of field DIS_ID

tblLAB

  • Added various codes to coding table of field LAB_ID

  • Added new optional field LAB_R

  • Added coding table for field LAB_ST

tblLAB_RES

  • Added new optional field PATHOGENTYPE

tblLAB_RES_LVL_3

  • Added new optional field RES_SCOR_ID

tblLAB_VIRO

  • Added new optional field VS_ST

tblLTFU

  • Added new optional field MOTHERDEATH_Y

  • Added new optional field MOTHERDEATH_D

  • Added new optional field FATHERDEATH_Y

  • Added new optional field FATHERDEATH_D

tblMED

  • Added new optional field MED_RS2

  • Added new optional field MED_RS3

  • Added new optional field MED_RS4

  • Added new optional field MEDSTART_RS

  • Added new optional field MED_DO

  • Added new optional field MED_FR

  • Added new optional field MED_DOT_Y

tblNEWBORN

  • Added new optional field ENTRY_PMTCT

  • Added new optional field BREASTFD_Y

  • Added new optional field BREASTFD_DUR

tblNEWBORN_ABNORM

  • Added IeDEA coding table for abnormalities

  • Added field ABNORM_T_S to distinguish new coding of abnormalities from old Hicdep-coding

tblPREG

  • Added new optional field EST_CONCEPT

  • Added new optional field PREG_TEST_D

  • Added new optional field NUM_FETUS

  • Added new optional field ULTR_3

  • Added new optional field ULTR_A_3

tblPREG_OUT

  • Added new optional field CHILD_HIV

  • Added new optional field CHILD_HIV_D

  • Added codes to field OUTCOM:

    • 4 = Born alive

    • 22 = Termination: method unknown

tblVIS

  • Added new optional field GENDER_ID

  • Added new optional field SCHOOL

  • Added new optional field SCHOOL_LVL

  • Added new optional field FEEDOTH_Y

  • Added new optional field CAREGIVER

  • Added new optional field BROUGHT_PATIENT

  • Added new optional field HIV_STATUS

  • Added new optional field STATUS_KNOWN

Added date precision annotation variables for many date variables (both existing and new ones above):

  • tblART: ART_SD_A, ART_ED_A

  • tblBAS: BIRTH_D_A, ENROL_D_A, RECART_D_A, AIDS_D_A

  • tblCANC: CANC_D_A

  • tblCENTER: LAST_REVIEWED_D_A

  • tbclDIS: DIS_D_A, DIS_ED_A

  • tblLAB: LAB_D_A

  • tblLAB_BP: BP_D_A

  • tblLAB_CD4: CD4_D_A

  • tblLAB_RES: SAMPLE_D_A, SEQ_DT_A

  • tblLAB_RNA: RNA_D_A

  • tblLTFU: DROP_D_A, DEATH_D_A, MOTHERDEATH_D_A, FATHERDEATH_D_A, L_ALIVE_D_A

  • tblMED: MED_SD_A, MED_ED_A

  • tblPREG: MENS_D_A, EST_CONCEPT_A, ANC_D_A, PREG_TEST_A

  • tblPREG_OUT: OUTCOME_D_A, CHILD_HIV_D_A

Version 1.90

tblART

  • added new optional field GENERIC

  • added new optional field ART_RS2

  • added new optional field ART_RS3

  • added new optional field ART_RS4

  • ART_ID

    • Added new single tablet formulations:

      • J05AR15 (Atazanavir and cobicistat)

      • J05AR16 (Lamivudine and raltegravir)

      • J05AR17 (Emtricitabine and tenofovir alafenamide)

      • J05AR18 (Emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat)

      • J05AR19 (Emtricitabine, tenofovir alafenamide and rilpivirine)

    • Deleted (moved to tblMED):

      • J05AF08";"Adefovir (PREVEON)"

      • J05AF10";"Entecavir"

      • J05AF11";"Telbivudine"

  • ART_RS

    • added new (sub-)codes for stopping medication

      • 11 (Bone toxicity)

      • 15 (Social contra-indication)

      • 16 (Contra-indication unspecified)

      • 16.8 (Contra-indication expired)

      • 16.9 (Contra-indication - other)

      • 17 (MTCT regimen completed)

      • 70 (Pregnancy - toxicity concerns (during pregnancy))

      • 75 (Pregnancy - switch to a more appropriate regimen for PMTCT)

      • 92.5 (Regular treatment termination (e.g. DAA's for HCV, antibiotics)

tblBAS

  • Added field for Center CENTER

tblCENTER

  • Added table

tblLAB

  • LAB_U

    • Deleted 18 (µkat/L, was same as 11)

tblLTFU

  • DEATH_R1

    • added new subcodes:

      • 03.1.3 (HCV with liver cancer)

      • 03.2.3 (HBV with liver cancer)

tblMED

  • MED_ID

    • Added new drug codes:

      • A11CC (vitamin D)

      • G02CA (Tocolysis)

      • H02 (Corticosteroids)

      • J01 (Antibiotics)

      • J01GA01 (streptomycin)

      • J02AC05 (Isavuconazole)

      • J02AX04 (caspofungin)

      • J04AB05 (Rifapentine (Priftin))

      • J05AF12 (Clevudine)

      • J05AX GRAZ-ELB (Grazoprevir/Elbasvir)

      • J05AR-DAAS (Daclatasvir/Asunaprevir)

      • J07BM0 (HPV Vaccine)

      • J07BM01 (HPV Vaccine (types 6, 11, 16, 18))

      • J07BM02 (HPV Vaccine (types 16, 18))

      • J07BM03 (HPV Vaccine (types 6, 11, 16, 18, 31, 33, 45, 52, 58))

      • M05BA (bisphosphonate)

      • N05A (Antipsychotics)

      • N05CD (Benzodiazepine derivatives)

      • N05CF (Benzodiazepine related drugs)

      • N06A (Antidepressant)

      • N07BC (Other drugs used in opioid dependence)

      • N07BC01 (Buprenorphine)

      • N07BC02 (Methadone)

      • N07BC03 (Levacetylmethadol)

      • N07BC04 (Lofexidine)

      • N07BC51 (Buprenorphine, combinations)

      • V03AB15 (Naloxone)

    • Added new drug codes (moved from tblART):

      • J05AF08";"Adefovir (PREVEON)"

      • J05AF10";"Entecavir"

      • J05AF11";"Telbivudine"

    • Changed temporary drug names to ATC codes:

      • J05AR-A450OM (ABT-450/r/Ombitasvir) --> J05AX67 (Ombitasvir, paritaprevir(ABT-450) and ritonavir)

      • J05AR-LESO (Ledipasvir/Sofosbuvir) --> J05AX65 (Ledipasvir/Sofosbuvir)

      • J05AX-DBV (Dasabuvir) --> J05AX16 (Dasabuvir)

  • MED_RS

    • added new (sub-)codes for stopping medication (to keep identical to ART_RS)

      • 11 (Bone toxicity)

      • 15 (Social contra-indication)

      • 16 (Contra-indication unspecified)

      • 16.8 (Contra-indication expired)

      • 16.9 (Contra-indication - other)

      • 17 (MTCT regimen completed)

      • 70 (Pregnancy - toxicity concerns (during pregnancy))

      • 75 (Pregnancy - switch to a more appropriate regimen for PMTCT)

      • 92.5 (Regular treatment termination (e.g. DAA's for HCV, antibiotics)

tblPROGRAM

  • Added table

tblVIS

  • Added field for Center CENTER

  • Added field for family history of CVD/Stroke FAM_Y

  • Added field for type of clinic/service CLIN_TYPE

  • Added field for speciality of physician SPEC_TYPE

  • Added field for stage of transition from adolescence to adulthood TRANS_STAGE

Version 1.80

tblART

  • ART_ID

    • Added:

      • J05AR11 (Lamivudine, tenofovir disoproxil and efavirenz)

      • J05AR12 (Lamivudine and tenofovir disoproxil)

      • J05AR13 (Lamivudine, abacavir and dolutegravir)

      • J05AR14 (Darunavir and cobicistat)

      • J05AX-CAB (Cabotegravir (GSK-744))

tblBAS

  • ETHNIC

    • Revised and added codes for different ethnicities

    • Changed limitations

    • Changed description

  • ORIGIN

    • Changed description to be more specific

tblCANC

  • Added table

tblLTFU

  • DEATH_R1

    • Added sub-types for 22 and 23

    • Added additional codes table

tblMED

  • MED_ID

    • Added:

      • J05AE11 (Telaprevir (INCIVEK, INCIVO))

      • J05AE13 (Faldaprevir)

      • J05AE14 (Simeprevir)

      • J05AE15 (Asunaprevir)

      • J05AX14 (Daclatasvir)

      • J05AX15 (Sofosbuvir)

      • J05AR-A450OM (ABT-450/r/Ombitasvir)

      • J05AR-DAAS (Daclatasvir/Asunaprevir)

      • J05AR-LESO (Ledipasvir/Sofosbuvir)

      • J05AX-DBV (Dasabuvir)

tblLAB

  • LAB_U

    • Added:

      • 14 (mg/24h)

      • 15 (mg/mmol)

      • 16 (fl)

      • 17 (µg/mL = mg/L)

      • 18 (µkat/L)

  • LAB_ID

    • Added:

      • ACRA (Albumin Creatinin Ratio)

      • PCRA (Protein Creatinin Ratio)

      • PROT (Protein)

      • PSA (Prostate-specific antigen)

      • PTH (Parathyroid Hormone)

Version 1.70

tblAE has been renamed to tblCEP

tblCEP

  • Added field CEP_V

  • CEP_ID

    • Added: HOSP, ICU, JAUN, LIVD, LIVT, USAB, ASP, BART, CHAG, NOCA, PCE, PMAR, REQU.

    • Added: BACT, ENDO, MENI, OSTI, PERI, PNEU, PYEL, LEIS, MCDI (Previously in tblDIS).

    • Removed: ANG, BYP, END as they are already in the field CEP_SPEC.

    • Removed COR as now specified with SUD_DEATH_Y and EXP_DEATH_Y in tblLTFU.

  • CEP_SPEC

    • Changed description of NADM - CERV to contain "grade 2 or higher"

    • Added values: LIVB - XX, HEP - XX, NADM - HENE, NADM - BRAIN

tblBAS

  • Added field RECART_D (Date ART started)

  • Added field LTART_D (Date last assessed for ART)

  • ETHNIC: Added Limitations section in description

  • Added field EDU_LVL (Last completed education Level)

  • Added field HIV_POS_D (Date of first positive HIV test)

tblDIS

  • DIS_ID:  Removed HG, BACT, ENDO, MENI, OSTI, PERI, PNEU, PYEL, LEIS, MCDI (now in tblCEP).

tblVIS

  • Added optional field EMPLOY (What is the patient's current situation regarding labour?)

  • Added optional field CONTRACT (If the patient is an employee, what is the type of the patient's employment contract?)

  • Added optional field SMOKING_Y (Is the patient currently a smoker?)

  • Added optional field PREG_Y (Is the patient currently pregnant?)

  • Added optional field CDC_STAGE

  • Added optional field WHO_STAGE

tblLTFU

  • Added optional fields for ICD9 cause of death coding (ICD9_#)

  • Added optional field DEATH_SOURCE

  • Added optional fields SUD_DEATH_Y and EXP_DEATH_Y. Replacing COR

  • CoDe

    • Typos in the coding table (HBF -> HBV)

    • New codes for cancer (04.XX)

    • New codes for AMI (08.XX)

    • New code: 92.1 - Unknown, competing risks

tblART

  • ART_ID: Coding extended/updated to match current ATC codes.

    • Lopinavir / Ritonavir changed code from "J05AE06" to "J05AR10".

    • Elvitegravir changed code from "J05AX-EVG" to "J05AX11"

    • J05AR07 - Triomune

    • J05AR08 - Eviplera / Complera

    • J05AR09 - Stribild

    • J05AR10 - Kaletra / Aluvia

    • J05AX12 - Dolutegravir

    • V03AX03 - Cobicistat

  • ART_FR: Added 0.33 and 0.5. Added special value -1 for "frequency unknown".

  • ART_RS

    • Added new codes: 6.X, 92.31, 92.32, 92.33, 92.4, 92.9, 94.2, 96.1, 96.2, 97.1, 97.2, 97.6

tblLAB

  • LAB_ID

    • Removed redundant "APT" code. Use code "ALP"

    • Removed "GLYCE" (synonymous to Glucose in blood)

    • Added "AFP" (Alfa Fetoprotein) and "DIPP" (Dipstick result for protein in Urine).

  • LAB_U

    • Removed WBC codes (WBC was already removed from LAB_ID)

    • Added generic "13 - µg/L" and "99 - No units" code

  • LAB_ST

    • Added codes U and U24.

tblLAB_RES

  • SUBTYPE Modified description to also include HCV

tblLAB_RNA

  • RNA_T

    • New code: 42 - Abbott RealTime HIV-1 m2000

    • New code: 59 - Monitor unspecified

tblMED

  • MED_ID

    • Changed description from "Other HIV-related drugs" to "Other medication"

    • Added codes for Boceprevir and Telaprevir

  • MED_RS

    • Same changes as in tblART ART_RS

tblLAB_VIRO

  • VS_T New codes 6,7,8.

Version 1.60

tblBAS

  • The ORIGIN field is now coded using UN region and country codes.

  • Added optional SEROHOW field indicating how the seroconversion date was determined.

  • Added optional CENS_D field holding the last date the database was updated for a patient.

tblREFILL

  • created to hold prescription refill data.

tblLTFU

  • The DEATH_R# fields now use CoDe codes for coding cause of death.

tblLAB

  • Added codes for Gamma-glutamyltransferase and Prothrombin rate.

tblLAB_VIRO

  • Changed code for "Other" of field VS_T to value 9.

  • Added "HBVACIGM", "HBVACIGG", "HCVBD" and "HDVA" codes for VS_ID field.

tblLAB_RES, tblLAB_RES_LVL_1, tblLAB_RES_LVL_2 and tblLAB_RES_LVL_3

  • Renamed SAMP_ID to TEST_ID, as it gives a better description of what the values should encode.

tblLAB_RES

  • Added a variable allowing to distinguish HIV- and HCV-resistance tests.

  • Added recommended and .

tblLAB_RES_LVL_3

  • ATC_CODE replaces ART_ID as HCV medication in tblMED may be encoded.

tblDIS

  • Added optional field for the end date of the disease.

tblMED

  • Added describing the reason for stopping the treatment; needed for HCV.

tblAE

  • Added a number of codes for : ANG, ASCI, AVN, BYP, CERC, END, FIBS, FRA, HEP, HESY, LAC, LIVB, OESO, PAN and PERI.

QA checks have been extended and updated where necessary.

Version 1.50

  • Added the pediatric tables: tblPREG, tblPREG_OBS, tblPREG_OUT, tblDELIVERY_MUM, tblDELIVERY_CHILD, tblNEWBORN and tblNEWBORN_ABNORM.

  • Added new table tblSAMPLES which holds information regarding sample storage.

tblART

  • Updated list of drugs

Version 1.30

tblART

  • Updated list of drugs

tblAE

  • added EVENT_ID as unique identifier and link to detailed tables for each event (see 1) – this replaces the optional AE_NO field.

  • added AE_SPEC to further specify an event by coding

  • a series of basic verification fields have been added to allow for tracking of event status for source documentation availability, verification of documentation (through monitoring) and final approval of the event.

  • in AE_R_Y - Relation to treatment: added more detailed codes.

tblLAB

  • added several codes for various biomarker tests.

tblLAB_CD4

  • added CD4_U as optional fields to discriminate between CD4% and CD4 cell count, so that the tblLAB_CD4 table can hold both types of measurements.

tblLAB_VIRO

  • added several codes for various virology and serology tests.

CaseDefinitionsupdated

  • updated with end stage renal disease, chronic liver disease and non-AIDS defining malignancies

Version 1.25

tblART

  • Updated list of drugs

tblMED

  • Updated list of drugs

tblDIS

  • Changed wording for CANO to ‘Candidiasis, oesophageal, bronchi, trachea, or lungs’

  • Added COCC - Coccidioidomycosis, disseminated or extrapulmonary

tblLAB

  • Added LAB_ST as additional field to code for type of specimen used for the measurement

tblLAB_CD4

  • Added CD4_U as additional field so the table can hold both percentage and absolute CD4 measurements

tblLAB_RNA

  • Added RNA_UL (upper limit of detection) to the list of additional fields.

  • Added more viral assays to the list of RNA_T codes

tblLAB_VIRO

  • Added unit field to tblLAB_VIRO into the general format and VS_LL (lower limit of detection), VS_UL (upper limit of detection) and VS_T (type of test) and list of tests to the list of additional fields.

tblLTFU

  • Added DEATH_RC# to code for causal relation of the DEATH_R# code to the death in order to comply with  CoDe and still maintain a format to be used for cohorts not using CoDe. ICD10_# fields have been moved to the list of additional fields.

Version 1.21

  • Added reasons for stopping treatment to table tblART_CODE_RS

Code Coding for Reason of Stopping Treatment

1.1 Virological failure

1.2 Partial virological failure

1.3 Immunological failure – CD4 drop

1.4 Clinical progression

90 Side effects – any of the above but unspecified

90.1 Comorbidity

92.1 Simplified treatment available

92.2 Treatment to complex

92.3 Drug interaction

93.1 Structured Treatment Interruption (STI) – at high CD4

94.1 Non-compliance

96 Pregnancy

97 Study treatment

Version 1.2

  • added CaseDefinitions

Version 1.1

tblBAS:

  • The table was split into tblBAS and tblLTFU. tblLTFU holds data on death and drop-out

  • Renamed LOS_Y to LOSS_Y

  • Renamed GAI_Y to GAIN_Y

tblLAB_BLP:

  • Renamed table to tblLAB_BP

  • Renamed BLP_D to BP_D

  • Renamed BLP_SYS to BP_SYS

  • Renamed BLP_DIA to BP_DIA

  • Renamed BLP_U to BP_U

Version 1.00

tblBas

  • Renamed BIRTHDAY to BIRTH_D

  • Renamed FIRSTVIS to FRSVIS_D

  • Renamed REC_ART to RECART_Y

tblLAB

  • LAB_U: has been dropped – please use the “unit codes/strings” as that is a safer way to code/represent the units – prefixing all “unit codes/strings” with a numeric value should however make analysis easier.

tblLAB_VIRO

  • New table added to capture mainly hepatitis measurements/tests

tblLAB_RES

  • SEQ_DT was added to capture the time of sequencing in order to facilitate quality assurance of the data for contamination that might have happened during the sequencing.

tblLAB_RES_LVL1

  • Renamed SEQ_ST to SEQ_STAR

  • SEQ_STOP: Added to the table to specify at which position in the sequence the sequencing was terminated

tblLAB_RES_LVL2

  • The table has been optimised for ease of analysis so that the mutation codes have been split into their components of amino acid position, sub position for insertions and 4 our more fields for mixtures of amino ac